Sonaro has successfully secured impact investment funding from the
MGH Foundation after a competitive pitch at the CLIP innovation
platform event. Recognized for its groundbreaking 3D
cardiovascular ultrasound technology, Sonaro was one of four
startups chosen from over 20 candidates.
This funding will enable the Montreal-based startup to scale its
innovative solution, which promises to significantly improve
cardiovascular care in Quebec and across Canada by offering more
accurate and accessible diagnostics. Sonaro's technology is poised
to make a substantial impact on patient outcomes, particularly in
the early detection and prevention of cardiovascular diseases.
Sonaro's Vaso3DTM revolutionizes carotid atherosclerosis diagnosis, reducing examination time by 90% with AI-driven 3D reconstructions.
Read more
Sonaro’s COO Karina Gasbarrino discusses the company’s Vaso3D technology and their plans for ViVe in Los Angeles, with support from McGill’s Dobson Centre driving their global healthcare impact.
Read more
Sonaro's CEO Kashif Khan was honored with the 2023 D. E. Strandness, M.D. Award at the SVU Annual Conference for his exceptional oral presentation on Sonaro’s innovative 3D vascular ultrasound technology.
Read more
The Ontario Brain Institute supports six neurotech startups, including Sonaro, with $600,000 to advance brain health solutions.
Read more
InfoBref features Sonaro's AI-driven 3D imaging software, highlighting its innovative approach to stroke prevention and recognition in Startup Montréal's Bourse+ program.
Read more
Sonaro earns recognition for its AI-powered 3D vessel reconstruction software, enhancing CVA prevention and ultrasound accessibility.
Read more
